Univariable analyses | Multivariable analysis | |||||
IRR | 95% CI | P value | aIRR | 95% CI | P value | |
Anti-TNF-α monotherapy | 1.67 | 0.92 to 3.06 | 0.10 | 1.66 | 0.91 to 3.04 | 0.10 |
Thiopurine monotherapy | 1.40 | 0.88 to 2.22 | 0.15 | 1.35 | 0.85 to 2.15 | 0.20 |
Anti-TNF-α and thiopurine | 1.63 | 0.71 to 3.78 | 0.25 | 1.65 | 0.71 to 3.82 | 0.24 |
Systemic corticosteroids | 1.55 | 0.97 to 2.50 | 0.07 | 1.52 | 0.94 to 2.44 | 0.09 |
Smoking during pregnancy | 1.52 | 0.70 to 3.32 | 0.29 | |||
Disease activity | 1.27 | 0.81 to 1.98 | 0.30 | |||
Obstetric complications | 0.92 | 0.49 to 1.74 | 0.80 | |||
Preterm birth | 1.17 | 0.66 to 2.05 | 0.60 | |||
Day care attendance | 1.14 | 0.60 to 2.15 | 0.69 | |||
Breast feeding (>1 month) | 0.95 | 0.64 to 1.40 | 0.79 |
aIRR, adjusted incidence rate ratio; IRR, incidence rate ratio ; TNF, tumour necrosis factor.